About Medical Progress Today

Medical Progress Today shows how market forces and capitalism can promote innovative new health technologies that save and extend human life, reduce disability, and help people lead more productive lives. It pulls together the best thoughts and best thinkers on these topics and serves as an online resource for those dedicated to pursuing medical progress in market driven, non-ideological approaches. Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

Paul Howard, Ph.D. is a Senior Fellow and the Director of the Manhattan Institute's Center for Medical Progress. He is the managing editor of Medical Progress Today, a web magazine devoted to chronicling the connection between private sector investment and biomedical innovation, market-friendly public policies, and improved health.

As editor, he has written on a wide variety of medical policy issues, including medical malpractice, FDA reform, and Medicare policy initiatives. He is often quoted on health care issues and his columns have appeared in newspapers across the country, including the New York Post, Dallas Morning News, Investor's Business Daily and WashingtonPost.com. He is also a member of the Manhattan Institute's Project FDA, a committee of physician-scientists, economists, medical ethicists, and policy experts. Their purpose is to show how 21st-century technologies can help better inform FDA regulations and accelerate the drug-development and drug-approval process while maintaining drug safety.

When Paul first joined the Manhattan Institute in 2000, he worked as the Deputy Director for the Center for Legal Policy where he edited research papers, managed legal policy analyses and organized conferences.

Articles/Op-Eds by Paul Howard

David Gratzer, a physician, is a senior fellow at the Manhattan Institute. Dr. Gratzer's research interests include Medicare and Medicaid, drug reimportation, and FDA reform. Nobel laureate Milton Friedman suggests that Dr. Gratzer is "a natural-born economist." David Gratzer's most recent book, with Foreword by Milton Friedman, is The Cure: How Capitalism Can Save American Health Care (Encounter Books, October 2006).

Articles/Op-Eds by David Gratzer

Regina E. Herzlinger is a Manhattan Institute Center for Medical Progress Senior Fellow. Herzlinger writes on Consumer-Driven Health Care issues and is the author of the new book Who Killed Health Care: America's $2 Trillion Problem - and the Consumer-Driven Cure (McGraw-Hill, June 2007). She is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and the first to serve on a number of corporate boards. She is widely recognized for her innovative research in health care, including her early predictions of the unravelling of managed care and the rise of consumer-driven health care and health care focused factories, two terms that she coined.

Articles/Op-Eds by Regina E. Herzlinger

Philip Stevens is the Director of Policy at the International Policy Network. He is author of numerous health policy publications, including Fighting the diseases of Poverty (2007), Free trade for better health (2006), and The 10/90 Gap and the diseases of poverty (2004). His writings on health policy have appeared in a wide range of international newspapers. Philip has also held research positions at the Adam Smith Institute and Reform in London, and spent several years as a management consultant. He holds degrees from the London School of Economics and Durham University.

Publications by Philip Stevens